aspergillomarasmine a has been researched along with tazobactam in 1 studies
Studies (aspergillomarasmine a) | Trials (aspergillomarasmine a) | Recent Studies (post-2010) (aspergillomarasmine a) | Studies (tazobactam) | Trials (tazobactam) | Recent Studies (post-2010) (tazobactam) |
---|---|---|---|---|---|
17 | 0 | 15 | 1,327 | 153 | 694 |
Protein | Taxonomy | aspergillomarasmine a (IC50) | tazobactam (IC50) |
---|---|---|---|
Beta-lactamase | Klebsiella pneumoniae | 0.08 | |
Beta-lactamase | Escherichia coli | 0.01 | |
Beta-lactamase | Citrobacter freundii | 0.096 | |
Beta-lactamase | Citrobacter gillenii | 0.04 | |
Beta-lactamase | Shouchella clausii | 0.004 | |
Beta-lactamase | Burkholderia cenocepacia | 0.5 | |
Beta-lactamase | Pseudomonas aeruginosa | 0.06 | |
Beta-lactamase | Pseudomonas aeruginosa | 2 | |
B2 bradykinin receptor | Cavia porcellus (domestic guinea pig) | 4.8 | |
Beta-lactamase | Staphylococcus aureus | 0.5 | |
Beta-lactamase | Bacillus licheniformis | 0.51 | |
Beta-lactamase | Escherichia coli K-12 | 0.25 | |
Beta-lactamase | Citrobacter freundii | 0.93 | |
Beta-lactamase | Enterobacter cloacae | 1.3748 | |
Beta-lactamase SHV-1 | Escherichia coli | 0.222 | |
Beta-lactamase SHV-1 | Klebsiella pneumoniae | 0.11 | |
Beta-lactamase OXA-1 | Escherichia coli | 4.8 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.83 | |
Cytochrome P450 2B6 | Homo sapiens (human) | 0.11 | |
Beta-lactamase | Pseudomonas aeruginosa PAO1 | 2.51 | |
Beta-lactamase TEM | Escherichia coli | 0.0828 | |
Beta-lactamase | Morganella morganii | 0.19 | |
Beta-lactamase | Salmonella enterica subsp. enterica serovar Westhampton | 0.0022 | |
Beta-lactamase | Pseudomonas aeruginosa | 2 | |
Beta-lactamase | Enterobacter cloacae | 0.03 | |
Class D beta-lactamase | Brachyspira pilosicoli | 0.16 | |
Beta-lactamase | Pseudomonas luteola | 0.04 | |
Beta-lactamase | Escherichia coli | 0.24 | |
Beta-lactamase | Serratia fonticola | 6.9 | |
Beta-lactamase | Enterobacter cloacae | 0.06 | |
Beta-lactamase | Escherichia coli | 0.002 | |
Carbapenem-hydrolyzing beta-lactamase KPC | Klebsiella pneumoniae | 0.372 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Colchón, E; González-Bello, C; Pernas, M; Rodríguez, Á; Rodríguez, D | 1 |
1 review(s) available for aspergillomarasmine a and tazobactam
Article | Year |
---|---|
β-Lactamase Inhibitors To Restore the Efficacy of Antibiotics against Superbugs.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; Drug Resistance, Microbial; Humans; Protein Structure, Secondary; Protein Structure, Tertiary; Treatment Outcome | 2020 |